About Credo Pharma
Credo Pharma is a Healthcare company based in Hyderabad (India) by Kandru Madhavarao. Integrated firm for manufacturing and trading niche pharmaceutical molecules. It operates on a B2B model. Its Indian entity Credo Pharma Private Limited reported revenue of ₹2.15 Cr. Credo Pharma offers products and services including Pharmaceutical Manufacturing. Its focus areas include Pharmaceuticals, Manufacturing and Specialty Molecules.
Company details
Credo Pharma Pvt. Ltd, based in Hyderabad, India, operates as an integrated company specializing in the manufacturing and trading of specialty and niche pharmaceutical molecules. It emphasizes credibility, commitment, quality, and timely delivery in its operations. The firm serves clients in the pharmaceutical sector through focused production and distribution activities, ensuring reliable supply chains.
- Headquarters Hyderabad, India
- Founders Kandru Madhavarao
- SectorsHealthcare
- Email••••••••
- Website credopharma.com
- Legal Name Credo Pharma Private Limited
- Date of Incorporation 23 Jul, 2013
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹2.15 Cr
FY 2025 · +10% YoY
- Net Loss-₹5.1 Lakh
FY 2025 · -2% margin
- EBITDA-₹4.3 Lakh
FY 2025 · -2% margin
Associated legal entities of Credo Pharma
Credo Pharma is associated with 2 registered companies on The Company Check; the primary company is Credo Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Credo Pharma Private Limited CIN U24232TG2013PTC089087 | Active | 23 Jul 2013 | Hyderabad, Telangana | ₹2.1 Cr | 4 | View details | |
| Auctus Life Sciences Llp CIN AAN-4398 | Active | 17 Oct 2018 | Hyderabad, Telangana | 6 | View details |
Products & Services of Credo Pharma
Credo Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Manufacturing.
Offers production and trading of specialty pharmaceutical molecules
Board of directors of Credo Pharma Private Limited (Credo Pharma)
Credo Pharma Private Limited is the primary company behind Credo Pharma. The boards of the 2 registered companies of Credo Pharma currently have 7 directors; the longest-serving is Kandru Madhavarao, appointed in 2013. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kandru Madhavarao DIN 06610196 | Director | 23 Jul 2013 | 13 yrs 3 mo | Credo Pharma Private Limited |
| Aluru Narmada DIN 07097387 | Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp, Credo Pharma Private Limited |
| Siva Rama Prasad Aluru DIN 00361671 | Designated Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp, Credo Pharma Private Limited |
| Sreenath Suryadevara DIN 07234232 | Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp |
| Lakshmi Devi Suryadevara DIN 06837476 | Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp |
| Aluru Vamsi Krishna DIN 06572638 | Designated Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp, Credo Pharma Private Limited |
| Suryadevara Venkateswara Rao DIN 00363121 | Designated Partner | 17 Oct 2018 | 8 yrs | Auctus Life Sciences Llp |
People of Credo Pharma
1 people are tracked at Credo Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership |
Complete people profiles for Credo Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Credo Pharma
Figures of Credo Pharma Private Limited, the primary company behind Credo Pharma, for FY 2025. Revenue was ₹2.15 Cr (+10% year on year). Net loss was -₹5.1 Lakh (-2% margin). EBITDA was -₹4.3 Lakh (-2% margin). Revenue has grown at a compounded annual rate of -4% over three years and +12% over five years.
- ₹2.15 CrRevenue · FY 2025 · +10% YoY
- -₹5.1 LakhNet loss · -2% margin
- -₹4.3 LakhEBITDA · -2% margin
- ₹1.12 CrPaid-up capital
- -4%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Credo Pharma Private Limited are on its company page.
Detailed financial statements for Credo Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Credo Pharma
Credo Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Credo Pharma, Credo Pharma Private Limited, reported revenue of ₹2.15 Cr for FY 2025, up 10% year on year.
Credo Pharma Pvt. Ltd, based in Hyderabad, India, operates as an integrated company specializing in the manufacturing and trading of specialty and niche pharmaceutical molecules. It emphasizes credibility, commitment, quality, and timely delivery in its operations. The firm serves clients in the pharmaceutical sector through focused production and distribution activities, ensuring reliable supply chains.
Credo Pharma offers Pharmaceutical Manufacturing.
Credo Pharma is associated with 2 legal entities: Credo Pharma Private Limited, Auctus Life Sciences Llp.
The legal entities of Credo Pharma currently have 7 directors, including Aluru Narmada, Siva Rama Prasad Aluru, Sreenath Suryadevara and others.